NEUROBIOLOGY AND PHARMACOLOGY OF RAPID ACTING ANTIDEPRESSANTS: POSTDOCTORAL FELLOWSHIP

A postdoctoral position is available on an NIH-funded research project to study the neurobiology and pharmacology of rapid-acting antidepressant drugs such as ketamine, as recently reported (Zanos et al., Nature, 2016 May 4;533(7604):481-6).

Our laboratory is broadly interested in using preclinical approaches to study mood disorder neurobiology, understand mechanism of drugs used to treat these conditions, and develop novel treatment approaches (see www.gouldlab.org). Techniques to be utilized may include electrophysiology, optogenetics, chemogenetics, fiber photometry, behavioral pharmacology, immunohistochemistry, transgenic/KO mice, and classical pharmacology. Experience in or interest in learning electrophysiology is preferred, and strong writing and communication skills as well as proficiency in English are essential. The successful candidate will play a lead role in designing and executing projects, writing publications, and presenting data at professional conferences. Salary will be based on experience. Interested applicants with a PhD in neuroscience, pharmacology, or related disciplines should send a CV, statement of research interests and the names of 2-3 references to: Dr. Todd Gould, Departments of Psychiatry, Pharmacology, and Anatomy and Neurobiology, via e-mail: gouldlab@me.com.